HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study (Q36984499)

17 August 2017

HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

1

1 reference

17 August 2017

2

Eric Boerwinkle

0 references

Eliseo Guallar

4

object named as

Eliseo Guallar

1 reference

17 August 2017

Paul C Adams

3

1 reference

17 August 2017

Catherine Leiendecker-Foster

5

1 reference

17 August 2017

Jason Rogowski

6

1 reference

17 August 2017

John H Eckfeldt

7

1 reference

17 August 2017

13 June 2008

1 reference

17 August 2017

Translational Research

1 reference

17 August 2017

152

1 reference

17 August 2017

3-10

1 reference

17 August 2017

1

1 reference

Iron-overload-related disease in HFE hereditary hemochromatosis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Biological variability of transferrin saturation and unsaturated iron-binding capacity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Hemochromatosis and iron-overload screening in a racially diverse population.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Clinical consequences of iron overload in hemochromatosis homozygotes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

A prospective study of venous thromboembolism in relation to factor V Leiden and related factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Screening for hemochromatosis: phenotype versus genotype

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Improving the detection and diagnosis of congestive heart failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Screening for hemochromatosis in asymptomatic subjects with or without a family history

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Hemochromatosis mutations in the general population: iron overload progression rate

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

HFE mutations and risk of coronary heart disease in middle-aged women

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2587433

Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons

4 December 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

High-resolution B-Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85-plus study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Beware of multiple comparisons: a study of symptoms associated with mutations of the HFE hemochromatosis gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.05.005

Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study

7 January 2021

1 reference

12 December 2020

ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies

1 reference

12 December 2020

High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). The ARIC Study Group

1 reference

12 December 2020

High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. The ARIC Study Group

1 reference

12 December 2020

10.1016/J.TRSL.2008.05.005

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference